More radiation may not improve survival in localized prostate cancer

Escalating the dose of radiation may not lead to increased survival for patients with localized and locally advanced prostate cancer (PCa), a new study finds. “In the field of radiation oncology, we often assume that the highest dose that the body can tolerate will be most effective at killing cancer,” lead researcher Robert Den, MD, associate professor of radiation oncology, cancer biology, and urology at Thomas Jefferson University in Philadelphia, stated in a press release. “Our results argue that this may not be the case, at least not with lower-risk prostate cancer patients.”

Renal & Urology News